Works matching IS 14642662 AND DT 2018 AND VI 19 AND IP 4

Results: 10

Rates of sustained virological response 12 weeks after the scheduled end of direct‐acting antiviral (DAA)‐based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
Published in:
HIV Medicine, 2018, v. 19, n. 4, p. 299, doi. 10.1111/hiv.12579
By:
- Bischoff, J.;
- Mauss, S.;
- Cordes, C.;
- Lutz, T.;
- Scholten, S.;
- Moll, A.;
- Jäger, H.;
- Cornberg, M.;
- Manns, M. P.;
- Baumgarten, A.;
- Rockstroh, J. K.
Publication type:
Article
Patient perspectives on de‐simplifying their single‐tablet co‐formulated antiretroviral therapy for societal cost savings.
Published in:
HIV Medicine, 2018, v. 19, n. 4, p. 290, doi. 10.1111/hiv.12578
By:
- Krentz, H. B.;
- Campbell, S.;
- Gill, V. C.;
- Gill, M. J.
Publication type:
Article
National audit of perinatal HIV infections in the UK, 2006–2013: what lessons can be learnt?
Published in:
HIV Medicine, 2018, v. 19, n. 4, p. 280, doi. 10.1111/hiv.12577
By:
- Peters, H.;
- Thorne, C.;
- Tookey, P. A.;
- Byrne, L.
Publication type:
Article
HIV prevalence among first‐presentation psychotic patients.
Published in:
HIV Medicine, 2018, v. 19, n. 4, p. 271, doi. 10.1111/hiv.12575
By:
- Laher, A.;
- Ariefdien, N.;
- Etlouba, Y.
Publication type:
Article
Sexualized drug use (‘chemsex’) and high‐risk sexual behaviours in HIV‐positive men who have sex with men.
Published in:
HIV Medicine, 2018, v. 19, n. 4, p. 261, doi. 10.1111/hiv.12574
By:
- Pufall, E. L.;
- Kall, M.;
- Shahmanesh, M.;
- Nardone, A.;
- Gilson, R.;
- Delpech, V.;
- Ward, H.;
- The Positive Voices study group
Publication type:
Article
Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort.
Published in:
HIV Medicine, 2018, v. 19, n. 4, p. 252, doi. 10.1111/hiv.12573
By:
- Roen, A.;
- Laut, K.;
- Pelchen‐Matthews, A.;
- Borodulina, E.;
- Caldeira, L.;
- Clarke, A.;
- Clotet, B.;
- d'Arminio Monforte, A.;
- Fätkenheuer, G.;
- Gatell Artigas, J. M.;
- Karpov, I.;
- Kuznetsova, A.;
- Kyselyova, G.;
- Mozer‐Lisewska, I.;
- Mulcahy, F.;
- Ragone, L.;
- Scherrer, A.;
- Uzdaviniene, V.;
- Vandekerckhove, L.;
- Vannappagari, V.
Publication type:
Article
Pre‐exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population.
Published in:
HIV Medicine, 2018, v. 19, n. 4, p. 243, doi. 10.1111/hiv.12572
By:
- Uthappa, C. K.;
- Allam, R. R.;
- Pant, R.;
- Pal, S.;
- Dinaker, M.;
- Oruganti, G.;
- Yeldandi, V. V.
Publication type:
Article
Issue Information.
Published in:
HIV Medicine, 2018, v. 19, n. 4, p. 1, doi. 10.1111/hiv.12550
Publication type:
Article
Severe depression as a neuropsychiatric side effect induced by dolutegravir.
Published in:
2018
By:
- Scheper, H.;
- van Holten, N.;
- Hovens, J. G. F. M.;
- de Boer, M. G. J.
Publication type:
Letter to the Editor
Importance of the patient‐physician interaction in assessing acceptability of HIV cure trials.
Published in:
2018
By:
- Protière, C.;
- Préau, M.;
- Carrieri, P.;
- Lambotte, O.;
- Spire, B.;
- Suzan‐Monti, M.
Publication type:
Letter to the Editor